Abstract:Objectives We sought to prospectively evaluate risk of stroke and impact of transcatheter patent foramen ovale (PFO) closure in patients with permanent right-to left shunt compared with those with Valsalva maneuver-induced right-toleft shunt.Background Pathophysiology and properly management of PFO still remain far from being fully clarified: in particular, the contribution of permanent right-to-left shunt remains unknown.Methods Between March 2006 and October 2010, we enrolled 180 (mean age 44 +/- 10.9 years, 98 women) of 320 consecutive patients referred to our center for transcatheter PFO closure, who had spontaneous permanent right-toleft shunt on transcranial Doppler and transthoracic/transesophageal echocardiography. All patients fulfilled the standard current indications for transcatheter closure and underwent preoperative transesophageal echocardiography and brain magnetic resonance imaging, with subsequent intracardiac echocardiographic-guided transcatheter PFO closure. We compared the clinical echocardiographic characteristics of these patients (Permanent Group) with the rest of 140 patients with right-to-left shunt only during Valsalva maneuver (Valsalva Group).Results Compared with the Valsalva Group patients, patients of the Permanent Group had increased frequency of multiple ischemic brain lesions on magnetic resonance imaging, previous recurrent stroke, previous peripheral arteries embolism, migraine with aura, and-more frequently-atrial septal aneurysm and prominent Eustachian valve. The presence of permanent shunt confers the highest risk of recurrent stroke (odds ratio: 5.9, 95% confidence interval: 2.0 to 12, p < 0.001). No differences were recorded between the 2 groups with regard to recurrence of ischemic events after the closure procedure.Conclusions Despite its small-sample nature, our study suggests that patients with permanent right-to-left shunt have potentially a higher risk of paradoxical embolism compared with those without. (J Am Coll Cardiol 2011;58:2257-61) (C) 2011 by the American College of Cardiology Foundation

Patent Foramen Ovale and Atrial Septal Defect

Patent Foramen Ovale: a Comprehensive Review for Pulmonologists

Patent Foramen Ovale with Paradoxical Embolism: Mid‐Term Results of Transcatheter Closure in 256 Patients

Asymptomatic Significant Patent Foramen Ovale: Giving Patent Foramen Ovale Management Back to the Cardiologist

Patent Foramen Ovale in Fetal Life, Infancy and Childhood

Patent Foramen Ovale Closure for Nonstroke Indications

[Patent foramen ovale and stroke]

Patent Foramen Ovale Closure in Special Clinical Situations: More Questions Than Answers?

[Patent Foramen Ovale: a Benign Anatomical Variant That Can Become a Disease].

Closing Patent Foramen Ovale in Cryptogenic Stroke: the Underscored Importance of Other Interatrial Shunt Variants

Transcatheter patent foramen ovale closure in spite of interatrial septum hypertrophy or lipomatosis: a case series.

Patent Foramen Ovale: The Unresolved Questions

Patent Foramen Ovale: the Evident Paradox Between the Apparently Simple Treatment and the Really Complex Pathophysiology

Transcatheters for Closure of Patent Foramen Ovales

Transcatheters for Closure of Patent Foramen Ovales.

Should We Consider Patent Foramen Ovale and Secundum Atrial Septal Defect As Different Steps of a Single Anatomo-Clinical Continuum?

Patent foramen ovale-obstructive sleep apnea relationships: pro and cons.

Current status of transcatheter closure of patent foramen ovale

Some Practical Points About Patent Foramen Ovale Conditions that May Not Be Covered in the Rest of the Book

Safety and Long-Term Results of Patent Foramen Ovale Transcatheter Closure in Patients with Thrombophilia.

Permanent Right-to-left Shunt is the Key Factor in Managing Patent Foramen Ovale.